Progenics Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsProgenics Pharmaceuticals

Progenics Pharmaceuticals(PGNX)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Azedra	Iobenguane i	2018-07-30		—

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Iobenguane i 131

,

neuroendocrine tumors

Lutetium dotatate lu-177

,

,

,

neuroendocrine carcinoma

,

,

,

pheochromocytoma

,

,

thyroid neoplasms

,

,

thyroid diseases

,

,

prostatic neoplasms

,

merkel cell carcinoma

,

small cell lung carcinoma

,

islet cell carcinoma

,

germ cell and embryonal neoplasms

,

,

medulloblastoma

,

pituitary neoplasms

,

parathyroid neoplasms

,

medullary carcinoma

,

pituitary diseases

,

,

malignant carcinoid syndrome

,

carcinoid heart disease

,

serotonin syndrome

,

disease progression

,

,

central nervous system neoplasms

,

,

nervous system neoplasms

,

diffuse intrinsic pontine glioma

,

small cell carcinoma

,

,

nasopharyngeal carcinoma

,

nasopharyngeal neoplasms

,

papillary thyroid cancer

,

carcinoid tumor

,

neoplasm metastasis

,

liver neoplasms

,

endocrine gland neoplasms

,

breast neoplasms

,

neuroendocrine tumors

,

,

pancreatic neoplasms

,

stomach neoplasms

,

intestinal neoplasms

,

islet cell adenoma

,

radiation dosimeters

,

hyperthyroidism

,

gastrointestinal neoplasms

,

digestive system neoplasms

,

gastrointestinal diseases

,

endocrine system diseases

,

neoplasms by histologic type

,

neoplasms by site

,

nerve tissue neoplasms

,

primitive neuroectodermal tumors

,

digestive system diseases

,

pancreatic diseases

,

intestinal diseases

,

neuroectodermal tumors

,

kidney diseases

,

,

Iobenguane i-131

pheochromocytoma

,

neuroendocrine tumors

,

hyperlipidemias

,

gastrointestinal stromal tumors

,

,

iron-deficiency anemia

,

iron deficiencies

,

,

,

,

small cell lung carcinoma

,

healthy volunteers/patients

,

,

primary myelofibrosis

,

myeloid leukemia acute

,

myeloid leukemia

,

,

hepatocellular carcinoma

,

,

plexiform neurofibroma

,

neurofibromatoses

,

,

,

,

chronic obstructive pulmonary disease

,

,

triple negative breast neoplasms

,

,

,

essential thrombocythemia

,

polycythemia vera

,

,

,

lupus nephritis

,

,

inflammatory breast neoplasms

,

prostatic neoplasms

,

precursor cell lymphoblastic leukemia-lymphoma

,

precursor t-cell lymphoblastic leukemia-lymphoma

,

b-cell chronic lymphocytic leukemia

,

lymphoid leukemia

,

,

wiskott-aldrich syndrome

,

bcr-abl positive chronic myelogenous leukemia

,

,

graft vs host disease

,

hematopoietic stem cell transplantation

,

bronchiolitis obliterans syndrome

,

,

hyperlipoproteinemia type ii

,

organ transplantation

,

homozygous familial hypercholesterolemia

,

cryopyrin-associated periodic syndromes

,

myelodysplastic syndromes

,

,

liver transplantation

,

thrombocytopenic purpura idiopathic

,

thrombocytopenic purpura

,

,

parkinson disease

,

,

,

juvenile arthritis

,

,

,

,

hepatitis b virus

,

,

,

,

vision disorders

,

,

pituitary acth hypersecretion

,

acth-secreting pituitary adenoma

,

,

acute coronary syndrome

,

,

,

pulmonary eosinophilia

,

pancreatic neoplasms

,

,

,

kidney transplantation

,

,

hypercholesterolemia

,

,

cardiovascular diseases

,

atherosclerosis

,

chronic kidney failure

,

kidney diseases

,

thrombocytopenia

,

breast neoplasms

,

,

renal insufficiency

,

,

,

,

chronic renal insufficiency

,

,

renal replacement therapy

,

drug-related side effects and adverse reactions

,

heart transplantation

,

polycystic kidney diseases

,

autosomal dominant polycystic kidney

,

,

,

cystic fibrosis

,

pseudomonas infections

,

type 2 diabetes mellitus

,

diabetes mellitus

,

multiple myeloma

,

plasma cell neoplasms

,

transplantation

,

cytomegalovirus infections

,

communicable diseases

,

metabolic syndrome

,

preconception care

,

drug interactions

,

percutaneous coronary intervention

,

,

Piflufolastat f-18

,

urogenital neoplasms

,

neoplasms by site

,

male genital diseases

,

prostatic diseases

,

male genital neoplasms

,

genital diseases

,

,

prostatic neoplasms

,

castration-resistant prostatic neoplasms

,

,

hypersensitivity

Piflufolastat f18

prostatic neoplasms

breast neoplasms

,

neoplasm metastasis

breast neoplasms

,

neoplasm metastasis

urethral neoplasms

,

transitional cell carcinoma

,

urologic neoplasms

,

small cell carcinoma

,

small cell lung carcinoma

,

neuroendocrine tumors

,

neuroendocrine carcinoma

,

kidney neoplasms

,

ureteral neoplasms

,

colorectal neoplasms

,

,

castration-resistant prostatic neoplasms

,

,

triple negative breast neoplasms

,

urinary bladder neoplasms

,

,

laryngeal neoplasms

,

laryngeal diseases

,

liver neoplasms

,

uterine cervical neoplasms

,

cholangiocarcinoma

,

gallbladder neoplasms

,

maxillary sinus neoplasms

,

neoplasm metastasis

,

,

prostatic neoplasms

,

non-small-cell lung carcinoma

,

,

squamous cell carcinoma of head and neck

,

esophageal neoplasms

,

ovarian neoplasms

,

squamous cell carcinoma

,

stomach neoplasms

,

,

endometrial neoplasms

,

ovarian epithelial carcinoma

,

fallopian tube neoplasms

,

nasopharyngeal carcinoma

,

nasopharyngeal neoplasms

,

head and neck neoplasms

,

disease progression

,

peritoneal neoplasms

,

squamous cell neoplasms

,

esophageal squamous cell carcinoma

,

breast neoplasms

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use